Phytochemical and Nephroprotective Evaluation of <i>Caralluma Subulata</i> From Jazan Province Against Cisplatin-Induced Nephrotoxicity Through Oxidative Stress, Inflammation, and Apoptosis In Rats

Objectives Cisplatin, a commonly utilized chemotherapeutic drug, is linked to dose-limiting nephrotoxicity caused by oxidative stress, inflammation, and apoptosis. This research assessed the phytochemical profile and nephroprotective efficacy of Caralluma subulata (Forssk.) Decne, a traditional medicinal plant from Jazan Province, Saudi Arabia, in mitigating cisplatin-induced renal damage in rats. Methods The aqueous-ethanolic extract of C. subulata was examined against cisplatin induced nephrotoxicity. Rats were categorized into control group, cisplatin group only (7 mg/kg bwt), treatment group with cisplatin combined with C. subulata (100 and 200 mg/kg bwt), and C. subulata (200 mg/kg bwt) only groups. Results The treatment of cisplatin (7 mg/kg bwt) markedly increased serum creatinine levels (305%) and blood urea nitrogen (BUN) levels (389%) in comparison to the control group while oxidative stress markers MDA and inflammatory cytokines also significantly increased. Pretreatment with C. Subulata (CS100 and CS200 mg/kg bwt. for 15 days) significantly mitigated cisplatin-induced renal damage by reducing the creatinine by 36.68% to 64.39%, BUN by 53.38% to 74.12%, MDA by 26.08% to 77.87% as compared to cisplatin induced nephrotoxicity. Pre-treatment with C. subulata (CS100 and CS200 mg/kg bwt) also enhances the antioxidant enzymes GSH by 6.48% to138.40%, SOD by 6.81% to137.93% and CAT by 1.86% to 121.50%. Similarly, C. subulata treatment also significantly decreases the pro-inflammatory cytokines TNF-α by 6.40% to 61.23%, IL-6 by 0.62% to 48.09% and apoptotic markers like caspase-3 reduced by 1.83% to 61.02%. These biochemical improvements were supported by histopathological evidence of reduced tubular necrosis and inflammation. Conclusion The studies demonstrate that C. subulata alleviates cisplatin nephrotoxicity via antioxidant, anti-inflammatory and anti-apoptotic mechanisms, so validating its traditional use and highlights its potential as an adjuvant therapy to attenuate chemotherapy-induced renal damage.

Authors

Institutions

Publication Details

Journal
Natural Product Communications
Published
2026-02-01
DOI
https://doi.org/10.1177/1934578x261417944
Primary Topic
Chemotherapy-induced organ toxicity mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phytochemical and Nephroprotective Evaluation of Caralluma Subulata From Jazan Province Against Cisplatin-Induced Nephrotoxicity Through Oxidative Stress, Inflammation, and Apoptosis In Rats

Zia ur Rehman, Hina Rashid, Ali Hanbashi, Santhosh Joseph Menachery et al.
Natural Product Communications
Chemotherapy-induced organ toxicity mitigation
article

Phytochemical and Nephroprotective Evaluation of Caralluma Subulata From Jazan Province Against Cisplatin-Induced Nephrotoxicity Through Oxidative Stress, Inflammation, and Apoptosis In Rats

Zia ur Rehman, Hina Rashid, Ali Hanbashi, Santhosh Joseph Menachery, Marwa Qadri, Basher M. Abdalsaed, Amna Shoaib, Tarique Anwer, Ali Mohammed Ali Hazazi, Ayed A Alshamrani, Mohammad Firoz Alam, Saeed Alshahrani
article en

Abstract

Objectives Cisplatin, a commonly utilized chemotherapeutic drug, is linked to dose-limiting nephrotoxicity caused by oxidative stress, inflammation, and apoptosis. This research assessed the phytochemical profile and nephroprotective efficacy of Caralluma subulata (Forssk.) Decne, a traditional medicinal plant from Jazan Province, Saudi Arabia, in mitigating cisplatin-induced renal damage in rats. Methods The aqueous-ethanolic extract of C. subulata was examined against cisplatin induced nephrotoxicity. Rats were categorized into control group, cisplatin group only (7 mg/kg bwt), treatment group with cisplatin combined with C. subulata (100 and 200 mg/kg bwt), and C. subulata (200 mg/kg bwt) only groups. Results The treatment of cisplatin (7 mg/kg bwt) markedly increased serum creatinine levels (305%) and blood urea nitrogen (BUN) levels (389%) in comparison to the control group while oxidative stress markers MDA and inflammatory cytokines also significantly increased. Pretreatment with C. Subulata (CS100 and CS200 mg/kg bwt. for 15 days) significantly mitigated cisplatin-induced renal damage by reducing the creatinine by 36.68% to 64.39%, BUN by 53.38% to 74.12%, MDA by 26.08% to 77.87% as compared to cisplatin induced nephrotoxicity. Pre-treatment with C. subulata (CS100 and CS200 mg/kg bwt) also enhances the antioxidant enzymes GSH by 6.48% to138.40%, SOD by 6.81% to137.93% and CAT by 1.86% to 121.50%. Similarly, C. subulata treatment also significantly decreases the pro-inflammatory cytokines TNF-α by 6.40% to 61.23%, IL-6 by 0.62% to 48.09% and apoptotic markers like caspase-3 reduced by 1.83% to 61.02%. These biochemical improvements were supported by histopathological evidence of reduced tubular necrosis and inflammation. Conclusion The studies demonstrate that C. subulata alleviates cisplatin nephrotoxicity via antioxidant, anti-inflammatory and anti-apoptotic mechanisms, so validating its traditional use and highlights its potential as an adjuvant therapy to attenuate chemotherapy-induced renal damage.

Natural Product CommunicationsVol. 21(2)
Alasmarya Islamic University (LY), Islamic University (BD), University of Bisha (SA), Jazan University (SA)
Openalex Percentile: Top 52%
Chemotherapy-induced organ toxicity mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.